Defining  ||| S:0 E:9 ||| FW
incidental  ||| S:9 E:20 ||| FW
perineural  ||| S:20 E:31 ||| FW
invasion ||| S:31 E:39 ||| FW
:  ||| S:39 E:41 ||| :
the  ||| S:41 E:45 ||| DT
need  ||| S:45 E:50 ||| NN
for  ||| S:50 E:54 ||| IN
a  ||| S:54 E:56 ||| DT
national  ||| S:56 E:65 ||| JJ
registry  ||| S:65 E:74 ||| NNS
This  ||| S:74 E:79 ||| DT
article  ||| S:79 E:87 ||| NN
by  ||| S:87 E:90 ||| IN
the  ||| S:90 E:94 ||| DT
Perineural  ||| S:94 E:105 ||| NNP
Invasion  ||| S:105 E:114 ||| NNP
( ||| S:114 E:115 ||| -LRB-
PNI ||| S:115 E:118 ||| NNP
)  ||| S:118 E:120 ||| -RRB-
Registry  ||| S:120 E:129 ||| NNP
Group  ||| S:129 E:135 ||| NNP
aims  ||| S:135 E:140 ||| VBZ
to  ||| S:140 E:143 ||| TO
clarify  ||| S:143 E:151 ||| VB
clinical  ||| S:151 E:160 ||| JJ
and  ||| S:160 E:164 ||| CC
histopathological  ||| S:164 E:182 ||| JJ
ambiguities  ||| S:182 E:194 ||| NNS
surrounding  ||| S:194 E:206 ||| VBG
PNI  ||| S:206 E:210 ||| NNP
in  ||| S:210 E:213 ||| IN
non-melanoma  ||| S:213 E:226 ||| JJ
skin  ||| S:226 E:231 ||| NN
cancer  ||| S:231 E:238 ||| NN
( ||| S:238 E:239 ||| -LRB-
NMSC ||| S:239 E:243 ||| NNP
) ||| S:243 E:244 ||| -RRB-
.  ||| S:244 E:246 ||| .
PNI  ||| S:246 E:250 ||| NNP
is  ||| S:250 E:253 ||| VBZ
reportedly  ||| S:253 E:264 ||| RB
present  ||| S:264 E:272 ||| VB
in  ||| S:272 E:275 ||| IN
approximately  ||| S:275 E:289 ||| RB
2-6 ||| S:289 E:292 ||| CD
%  ||| S:292 E:294 ||| NN
of  ||| S:294 E:297 ||| IN
cases  ||| S:297 E:303 ||| NNS
of  ||| S:303 E:306 ||| IN
NMSC  ||| S:306 E:311 ||| NNP
and  ||| S:311 E:315 ||| CC
is  ||| S:315 E:318 ||| VBZ
associated  ||| S:318 E:329 ||| VBN
with  ||| S:329 E:334 ||| IN
greater  ||| S:334 E:342 ||| JJR
rates  ||| S:342 E:348 ||| NNS
of  ||| S:348 E:351 ||| IN
morbidity  ||| S:351 E:361 ||| NN
and  ||| S:361 E:365 ||| CC
mortality ||| S:365 E:374 ||| NN
.  ||| S:374 E:376 ||| .
The  ||| S:376 E:380 ||| DT
distinction  ||| S:380 E:392 ||| NN
between  ||| S:392 E:400 ||| IN
clinical  ||| S:400 E:409 ||| JJ
PNI  ||| S:409 E:413 ||| NNP
and  ||| S:413 E:417 ||| CC
incidental  ||| S:417 E:428 ||| JJ
PNI  ||| S:428 E:432 ||| NNP
is  ||| S:432 E:435 ||| VBZ
somewhat  ||| S:435 E:444 ||| RB
unclear ||| S:444 E:451 ||| JJ
,  ||| S:451 E:453 ||| ,
especially  ||| S:453 E:464 ||| RB
in  ||| S:464 E:467 ||| IN
regard  ||| S:467 E:474 ||| NN
to  ||| S:474 E:477 ||| TO
management  ||| S:477 E:488 ||| NN
and  ||| S:488 E:492 ||| CC
prognosis ||| S:492 E:501 ||| NN
.  ||| S:501 E:503 ||| .
One  ||| S:503 E:507 ||| CD
important  ||| S:507 E:517 ||| JJ
objective  ||| S:517 E:527 ||| NN
of  ||| S:527 E:530 ||| IN
the  ||| S:530 E:534 ||| DT
PNI  ||| S:534 E:538 ||| NNP
Registry  ||| S:538 E:547 ||| NNP
is  ||| S:547 E:550 ||| VBZ
to  ||| S:550 E:553 ||| TO
develop  ||| S:553 E:561 ||| VB
a  ||| S:561 E:563 ||| DT
standardised  ||| S:563 E:576 ||| JJ
method  ||| S:576 E:583 ||| NN
of  ||| S:583 E:586 ||| IN
classifying  ||| S:586 E:598 ||| JJ
perineural  ||| S:598 E:609 ||| JJ
invasion ||| S:609 E:617 ||| NN
.  ||| S:617 E:619 ||| .
Hence ||| S:619 E:624 ||| RB
,  ||| S:624 E:626 ||| ,
in  ||| S:626 E:629 ||| IN
this  ||| S:629 E:634 ||| DT
article  ||| S:634 E:642 ||| NN
we  ||| S:642 E:645 ||| PRP
propose  ||| S:645 E:653 ||| VBP
a  ||| S:653 E:655 ||| DT
definition  ||| S:655 E:666 ||| NN
for  ||| S:666 E:670 ||| IN
PNI  ||| S:670 E:674 ||| NNP
and  ||| S:674 E:678 ||| CC
for  ||| S:678 E:682 ||| IN
its  ||| S:682 E:686 ||| PRP$
sub-classification ||| S:686 E:704 ||| JJ
.  ||| S:704 E:706 ||| .
This  ||| S:706 E:711 ||| DT
article  ||| S:711 E:719 ||| NN
also  ||| S:719 E:724 ||| RB
provides  ||| S:724 E:733 ||| VBZ
a  ||| S:733 E:735 ||| DT
critical  ||| S:735 E:744 ||| JJ
analysis  ||| S:744 E:753 ||| NN
of  ||| S:753 E:756 ||| IN
the  ||| S:756 E:760 ||| DT
current  ||| S:760 E:768 ||| JJ
literature  ||| S:768 E:779 ||| NN
on  ||| S:779 E:782 ||| IN
the  ||| S:782 E:786 ||| DT
treatment  ||| S:786 E:796 ||| NN
of  ||| S:796 E:799 ||| IN
incidental  ||| S:799 E:810 ||| JJ
PNI  ||| S:810 E:814 ||| NN
by  ||| S:814 E:817 ||| IN
evaluating  ||| S:817 E:828 ||| VBG
the  ||| S:828 E:832 ||| DT
key  ||| S:832 E:836 ||| JJ
cohort  ||| S:836 E:843 ||| JJ
studies  ||| S:843 E:851 ||| NNS
that  ||| S:851 E:856 ||| WDT
have  ||| S:856 E:861 ||| VBP
investigated  ||| S:861 E:874 ||| VBN
the  ||| S:874 E:878 ||| DT
use  ||| S:878 E:882 ||| NN
of  ||| S:882 E:885 ||| IN
surgery  ||| S:885 E:893 ||| NN
or  ||| S:893 E:896 ||| CC
radiotherapy  ||| S:896 E:909 ||| NN
in  ||| S:909 E:912 ||| IN
the  ||| S:912 E:916 ||| DT
management  ||| S:916 E:927 ||| NN
of  ||| S:927 E:930 ||| IN
incidental  ||| S:930 E:941 ||| JJ
PNI ||| S:941 E:944 ||| NNP
.  ||| S:944 E:946 ||| .
At  ||| S:946 E:949 ||| IN
present ||| S:949 E:956 ||| JJ
,  ||| S:956 E:958 ||| ,
there  ||| S:958 E:964 ||| EX
are  ||| S:964 E:968 ||| VBP
no  ||| S:968 E:971 ||| DT
universal  ||| S:971 E:981 ||| JJ
clinical  ||| S:981 E:990 ||| JJ
guidelines  ||| S:990 E:1001 ||| NNS
that  ||| S:1001 E:1006 ||| WDT
specify  ||| S:1006 E:1014 ||| VBZ
the  ||| S:1014 E:1018 ||| DT
acceptable  ||| S:1018 E:1029 ||| JJ
treatment  ||| S:1029 E:1039 ||| NN
of  ||| S:1039 E:1042 ||| IN
NMSC  ||| S:1042 E:1047 ||| NNP
exhibiting  ||| S:1047 E:1058 ||| FW
incidental  ||| S:1058 E:1069 ||| FW
PNI ||| S:1069 E:1072 ||| FW
.  ||| S:1072 E:1074 ||| .
Consequently ||| S:1074 E:1086 ||| RB
,  ||| S:1086 E:1088 ||| ,
patients  ||| S:1088 E:1097 ||| NNS
often  ||| S:1097 E:1103 ||| RB
receive  ||| S:1103 E:1111 ||| VB
surgery  ||| S:1111 E:1119 ||| NN
with  ||| S:1119 E:1124 ||| IN
varying  ||| S:1124 E:1132 ||| VBG
wider  ||| S:1132 E:1138 ||| JJR
margins ||| S:1138 E:1145 ||| NNS
,  ||| S:1145 E:1147 ||| ,
or  ||| S:1147 E:1150 ||| CC
radiotherapy  ||| S:1150 E:1163 ||| NN
despite  ||| S:1163 E:1171 ||| IN
the  ||| S:1171 E:1175 ||| DT
limited  ||| S:1175 E:1183 ||| JJ
evidence  ||| S:1183 E:1192 ||| NN
substantiating  ||| S:1192 E:1207 ||| VBZ
such  ||| S:1207 E:1212 ||| JJ
management  ||| S:1212 E:1223 ||| NN
options ||| S:1223 E:1230 ||| NNS
.  ||| S:1230 E:1232 ||| .
It  ||| S:1232 E:1235 ||| PRP
is  ||| S:1235 E:1238 ||| VBZ
evident  ||| S:1238 E:1246 ||| JJ
from  ||| S:1246 E:1251 ||| IN
the  ||| S:1251 E:1255 ||| DT
existing  ||| S:1255 E:1264 ||| JJ
literature  ||| S:1264 E:1275 ||| NN
that  ||| S:1275 E:1280 ||| IN
current  ||| S:1280 E:1288 ||| JJ
opinion  ||| S:1288 E:1296 ||| NN
is  ||| S:1296 E:1299 ||| VBZ
divided  ||| S:1299 E:1307 ||| VBN
over  ||| S:1307 E:1312 ||| IN
the  ||| S:1312 E:1316 ||| DT
benefit  ||| S:1316 E:1324 ||| NN
of  ||| S:1324 E:1327 ||| IN
adjuvant  ||| S:1327 E:1336 ||| JJ
radiotherapy ||| S:1336 E:1348 ||| NN
.  ||| S:1348 E:1350 ||| .
Certain  ||| S:1350 E:1358 ||| JJ
prognostic  ||| S:1358 E:1369 ||| JJ
factors  ||| S:1369 E:1377 ||| NNS
have  ||| S:1377 E:1382 ||| VBP
been  ||| S:1382 E:1387 ||| VBN
proposed ||| S:1387 E:1395 ||| VBN
,  ||| S:1395 E:1397 ||| ,
such  ||| S:1397 E:1402 ||| JJ
as  ||| S:1402 E:1405 ||| IN
the  ||| S:1405 E:1409 ||| DT
size  ||| S:1409 E:1414 ||| NN
and  ||| S:1414 E:1418 ||| CC
depth  ||| S:1418 E:1424 ||| NN
of  ||| S:1424 E:1427 ||| IN
tumour  ||| S:1427 E:1434 ||| JJ
invasion ||| S:1434 E:1442 ||| NN
,  ||| S:1442 E:1444 ||| ,
nerve  ||| S:1444 E:1450 ||| JJ
diameter ||| S:1450 E:1458 ||| NN
,  ||| S:1458 E:1460 ||| ,
the  ||| S:1460 E:1464 ||| DT
presence  ||| S:1464 E:1473 ||| NN
of  ||| S:1473 E:1476 ||| IN
multifocal  ||| S:1476 E:1487 ||| JJ
PNI  ||| S:1487 E:1491 ||| NNP
and  ||| S:1491 E:1495 ||| CC
the  ||| S:1495 E:1499 ||| DT
type  ||| S:1499 E:1504 ||| NN
of  ||| S:1504 E:1507 ||| IN
tumour ||| S:1507 E:1513 ||| NN
.  ||| S:1513 E:1515 ||| .
The  ||| S:1515 E:1519 ||| DT
PNI  ||| S:1519 E:1523 ||| NNP
Registry  ||| S:1523 E:1532 ||| NNP
is  ||| S:1532 E:1535 ||| VBZ
a  ||| S:1535 E:1537 ||| DT
web-based  ||| S:1537 E:1547 ||| JJ
registry  ||| S:1547 E:1556 ||| NN
that  ||| S:1556 E:1561 ||| WDT
has  ||| S:1561 E:1565 ||| VBZ
been  ||| S:1565 E:1570 ||| VBN
developed  ||| S:1570 E:1580 ||| VBN
to  ||| S:1580 E:1583 ||| TO
assist  ||| S:1583 E:1590 ||| VB
in  ||| S:1590 E:1593 ||| IN
attaining  ||| S:1593 E:1603 ||| JJ
further  ||| S:1603 E:1611 ||| JJ
data  ||| S:1611 E:1616 ||| NNS
pertaining  ||| S:1616 E:1627 ||| VBP
to  ||| S:1627 E:1630 ||| TO
incidental  ||| S:1630 E:1641 ||| VB
PNI  ||| S:1641 E:1645 ||| NNP
in  ||| S:1645 E:1648 ||| IN
NMSC ||| S:1648 E:1652 ||| NNP
.  ||| S:1652 E:1654 ||| .
It  ||| S:1654 E:1657 ||| PRP
is  ||| S:1657 E:1660 ||| VBZ
envisaged  ||| S:1660 E:1670 ||| VBN
that  ||| S:1670 E:1675 ||| IN
this  ||| S:1675 E:1680 ||| DT
information  ||| S:1680 E:1692 ||| NN
will  ||| S:1692 E:1697 ||| MD
provide  ||| S:1697 E:1705 ||| VB
the  ||| S:1705 E:1709 ||| DT
foundation  ||| S:1709 E:1720 ||| NN
for  ||| S:1720 E:1724 ||| IN
identifying  ||| S:1724 E:1736 ||| VBG
and  ||| S:1736 E:1740 ||| CC
defining  ||| S:1740 E:1749 ||| JJ
best  ||| S:1749 E:1754 ||| JJS
practice  ||| S:1754 E:1763 ||| NN
in  ||| S:1763 E:1766 ||| IN
managing  ||| S:1766 E:1775 ||| VBG
incidental  ||| S:1775 E:1786 ||| JJ
PNI ||| S:1786 E:1789 ||| NNP
.  ||| S:1789 E:1791 ||| .
